How Do You Feel on Wegovy — and Does It Change Over Time?

Appetite reduction is typically the first noticeable change, often within days of the first dose.
Gastrointestinal effects (nausea, loose stools, constipation, or reflux) are the most commonly reported side effects and are usually temporary.
Fatigue and mild headache can appear during the early weeks, especially around each dose increase.
Many people report that the side-effect picture shifts noticeably once they have been on a stable dose for several weeks.

Most people starting Wegovy notice a significant reduction in appetite within the first week or two, often alongside some nausea or digestive discomfort that tends to ease as the body adjusts. That shift in how food feels (less urgent, less constant) is central to how semaglutide works. These are prescription-only medicines requiring clinical assessment before anyone can start them, and individual experience varies considerably. What follows is an honest account of what the evidence and clinical practice actually show, drawn from NHS guidance on semaglutide and the published trial data.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The honest week-by-week picture: what people actually experience on Wegovy

What does Wegovy feel like in the first few weeks?

The earliest change most people describe is not dramatic — it is subtler than that. Food stops feeling like a priority. A meal that used to occupy your thoughts from mid-morning arrives and you finish half of it without effort. That shift in appetite is semaglutide's primary mechanism: it activates GLP-1 receptors that signal fullness and slow the rate at which the stomach empties, so the brain receives a "still working on it" signal for longer than usual.

Alongside that, nausea is common in the opening weeks. It tends to peak in the hours after an injection, then settles. Loose stools, constipation, or an uncomfortable bloated feeling are also reported by a significant proportion of people. These effects are generally mild to moderate and transient, though they can be unsettling if you are not expecting them. Fatigue shows up too, particularly around the time of the first couple of dose increases. A low-grade headache in week one or two is not unusual.

The prescribing schedule starts at 0.25mg precisely because the body needs time to adapt. Jumping straight to a higher dose without that adjustment period tends to produce more pronounced side effects. If you want a fuller picture before you begin, our page on how Wegovy makes you feel walks through the experience across the whole course of treatment, while our page on how you feel after taking Wegovy covers the immediate post-injection window in more detail if that is your specific concern.

Does the way you feel settle down as treatment continues?

For most people, yes, though the timeline varies. The GI effects that dominate the first month or so typically improve once the dose has been stable for a few weeks. The body adjusts to the slower gastric emptying, and nausea in particular tends to become less frequent and less intense as treatment continues.

What tends to persist, and what most people are glad to keep, is the appetite change. That quieter relationship with food (fewer intrusive hunger signals, greater satisfaction from smaller amounts) is what drives the weight loss seen in the STEP 1 trial, which found an average body-weight reduction of around 15% over 68 weeks at the 2.4mg maintenance dose, compared with placebo. The full trial paper is published in the New England Journal of Medicine for anyone who wants the primary data.

Energy levels for many people stabilise or improve once initial GI symptoms ease, particularly as the body adjusts to taking in less food. That said, some people continue to notice episodes of tiredness, especially after dose increases. Tracking how you feel in a simple notes app (even just a line per week) is a low-effort habit that makes conversations with your prescriber considerably more useful. One minute, once a week. Worth doing.

A small number of people find that certain effects, such as a sensitivity to cold, persist further into treatment. If that sounds familiar, our dedicated page on feeling cold on Wegovy covers what is known about that experience.

Are there effects that need prompt medical attention?

Most of what people feel on Wegovy is manageable and expected. But some symptoms warrant the same-day response: severe or persistent stomach pain that extends towards the back, with or without vomiting, should not be waited out, because acute pancreatitis is a recognised (if infrequent) side effect of GLP-1 medicines. The MHRA highlighted this in a formal Drug Safety Update in January 2026. Signs of a serious allergic reaction (swelling of the face or throat, difficulty breathing, rapid heartbeat) also require immediate emergency care.

Gallbladder symptoms (sharp upper-right abdominal pain, especially after eating) are worth reporting to your prescriber promptly. Significant vomiting or diarrhoea that prevents keeping fluids down can cause dehydration quickly; if that happens, seek medical advice rather than waiting for the next injection day. Any suspected side effect can be reported directly through the MHRA Yellow Card scheme, which exists precisely to track real-world safety data on medicines like Wegovy.

These are prescription medicines for a reason. A prescriber who knows your health history is in a much stronger position than an article to judge whether a symptom you are experiencing needs attention or is simply the expected early-weeks adjustment. If you are curious about strategies to get through the trickier early phase, our page on managing how you feel on Wegovy has practical suggestions.

Considering treatment and want to know whether you are likely to be a good candidate? The Wegovy overview page covers eligibility, the licensed dose schedule, and what the full private-treatment route looks like. And if cost is part of the decision, an honest breakdown of what private treatment typically involves is on our Wegovy pricing page.

These are prescription-only medicines. A clinician reviews every consultation at nume, a named prescriber reads your answers, not software. If you are ready to find out whether Wegovy is clinically appropriate for you, speak to our prescribers through a free consultation.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions